
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen
Joseph G. Jardine, Takayuki Ota, Devin Sok, et al.
Science (2015) Vol. 349, Iss. 6244, pp. 156-161
Open Access | Times Cited: 394
Joseph G. Jardine, Takayuki Ota, Devin Sok, et al.
Science (2015) Vol. 349, Iss. 6244, pp. 156-161
Open Access | Times Cited: 394
Showing 1-25 of 394 citing articles:
Structural basis of a shared antibody response to SARS-CoV-2
Meng Yuan, Hejun Liu, Nicholas C. Wu, et al.
Science (2020) Vol. 369, Iss. 6507, pp. 1119-1123
Open Access | Times Cited: 633
Meng Yuan, Hejun Liu, Nicholas C. Wu, et al.
Science (2020) Vol. 369, Iss. 6507, pp. 1119-1123
Open Access | Times Cited: 633
Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
Dennis R. Burton, Lars Hangartner
Annual Review of Immunology (2016) Vol. 34, Iss. 1, pp. 635-659
Open Access | Times Cited: 552
Dennis R. Burton, Lars Hangartner
Annual Review of Immunology (2016) Vol. 34, Iss. 1, pp. 635-659
Open Access | Times Cited: 552
HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen
Joseph G. Jardine, Daniel W. Kulp, Colin Havenar‐Daughton, et al.
Science (2016) Vol. 351, Iss. 6280, pp. 1458-1463
Open Access | Times Cited: 430
Joseph G. Jardine, Daniel W. Kulp, Colin Havenar‐Daughton, et al.
Science (2016) Vol. 351, Iss. 6280, pp. 1458-1463
Open Access | Times Cited: 430
3D printing in chemical engineering and catalytic technology: structured catalysts, mixers and reactors
Cesar Parra‐Cabrera, Clement Achille, Simon Kuhn, et al.
Chemical Society Reviews (2017) Vol. 47, Iss. 1, pp. 209-230
Open Access | Times Cited: 430
Cesar Parra‐Cabrera, Clement Achille, Simon Kuhn, et al.
Chemical Society Reviews (2017) Vol. 47, Iss. 1, pp. 209-230
Open Access | Times Cited: 430
Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus
Jessica Marcandalli, Brooke Fiala, Sebastian Ols, et al.
Cell (2019) Vol. 176, Iss. 6, pp. 1420-1431.e17
Open Access | Times Cited: 418
Jessica Marcandalli, Brooke Fiala, Sebastian Ols, et al.
Cell (2019) Vol. 176, Iss. 6, pp. 1420-1431.e17
Open Access | Times Cited: 418
Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G
Guillaume B. E. Stewart-Jones, Cinque Soto, Thomas Lemmin, et al.
Cell (2016) Vol. 165, Iss. 4, pp. 813-826
Open Access | Times Cited: 409
Guillaume B. E. Stewart-Jones, Cinque Soto, Thomas Lemmin, et al.
Cell (2016) Vol. 165, Iss. 4, pp. 813-826
Open Access | Times Cited: 409
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies
Jon M. Steichen, Daniel W. Kulp, Talar Tokatlian, et al.
Immunity (2016) Vol. 45, Iss. 3, pp. 483-496
Open Access | Times Cited: 391
Jon M. Steichen, Daniel W. Kulp, Talar Tokatlian, et al.
Immunity (2016) Vol. 45, Iss. 3, pp. 483-496
Open Access | Times Cited: 391
Recent progress in broadly neutralizing antibodies to HIV
Devin Sok, Dennis R. Burton
Nature Immunology (2018) Vol. 19, Iss. 11, pp. 1179-1188
Open Access | Times Cited: 391
Devin Sok, Dennis R. Burton
Nature Immunology (2018) Vol. 19, Iss. 11, pp. 1179-1188
Open Access | Times Cited: 391
Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design
Rino Rappuoli, Matthew J. Bottomley, Ugo D’Oro, et al.
The Journal of Experimental Medicine (2016) Vol. 213, Iss. 4, pp. 469-481
Open Access | Times Cited: 362
Rino Rappuoli, Matthew J. Bottomley, Ugo D’Oro, et al.
The Journal of Experimental Medicine (2016) Vol. 213, Iss. 4, pp. 469-481
Open Access | Times Cited: 362
Role of nanoscale antigen organization on B-cell activation probed using DNA origami
Rémi Veneziano, Tyson J. Moyer, Matthew B. Stone, et al.
Nature Nanotechnology (2020) Vol. 15, Iss. 8, pp. 716-723
Open Access | Times Cited: 358
Rémi Veneziano, Tyson J. Moyer, Matthew B. Stone, et al.
Nature Nanotechnology (2020) Vol. 15, Iss. 8, pp. 716-723
Open Access | Times Cited: 358
Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes
Steven W. de Taeye, Gabriel Ozorowski, Alba Torrents de la Peña, et al.
Cell (2015) Vol. 163, Iss. 7, pp. 1702-1715
Open Access | Times Cited: 354
Steven W. de Taeye, Gabriel Ozorowski, Alba Torrents de la Peña, et al.
Cell (2015) Vol. 163, Iss. 7, pp. 1702-1715
Open Access | Times Cited: 354
Beyond antigens and adjuvants: formulating future vaccines
Tyson J. Moyer, Andrew C. Zmolek, Darrell J. Irvine
Journal of Clinical Investigation (2016) Vol. 126, Iss. 3, pp. 799-808
Open Access | Times Cited: 346
Tyson J. Moyer, Andrew C. Zmolek, Darrell J. Irvine
Journal of Clinical Investigation (2016) Vol. 126, Iss. 3, pp. 799-808
Open Access | Times Cited: 346
Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens
Robert Abbott, Jeong Hyun Lee, Sergey Menis, et al.
Immunity (2017) Vol. 48, Iss. 1, pp. 133-146.e6
Open Access | Times Cited: 315
Robert Abbott, Jeong Hyun Lee, Sergey Menis, et al.
Immunity (2017) Vol. 48, Iss. 1, pp. 133-146.e6
Open Access | Times Cited: 315
Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses
Michael Joyce, Adam K. Wheatley, Paul V. Thomas, et al.
Cell (2016) Vol. 166, Iss. 3, pp. 609-623
Open Access | Times Cited: 314
Michael Joyce, Adam K. Wheatley, Paul V. Thomas, et al.
Cell (2016) Vol. 166, Iss. 3, pp. 609-623
Open Access | Times Cited: 314
CXCL13 is a plasma biomarker of germinal center activity
Colin Havenar‐Daughton, Madelene Lindqvist, Antje Heit, et al.
Proceedings of the National Academy of Sciences (2016) Vol. 113, Iss. 10, pp. 2702-2707
Open Access | Times Cited: 308
Colin Havenar‐Daughton, Madelene Lindqvist, Antje Heit, et al.
Proceedings of the National Academy of Sciences (2016) Vol. 113, Iss. 10, pp. 2702-2707
Open Access | Times Cited: 308
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody
Mattia Bonsignori, Tongqing Zhou, Zizhang Sheng, et al.
Cell (2016) Vol. 165, Iss. 2, pp. 449-463
Open Access | Times Cited: 307
Mattia Bonsignori, Tongqing Zhou, Zizhang Sheng, et al.
Cell (2016) Vol. 165, Iss. 2, pp. 449-463
Open Access | Times Cited: 307
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure
Peter D. Kwong, John R. Mascola
Immunity (2018) Vol. 48, Iss. 5, pp. 855-871
Open Access | Times Cited: 307
Peter D. Kwong, John R. Mascola
Immunity (2018) Vol. 48, Iss. 5, pp. 855-871
Open Access | Times Cited: 307
Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice
Amelia Escolano, Jon M. Steichen, Pia Dosenovic, et al.
Cell (2016) Vol. 166, Iss. 6, pp. 1445-1458.e12
Open Access | Times Cited: 304
Amelia Escolano, Jon M. Steichen, Pia Dosenovic, et al.
Cell (2016) Vol. 166, Iss. 6, pp. 1445-1458.e12
Open Access | Times Cited: 304
Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers
Talar Tokatlian, Benjamin J. Read, Christopher A. Jones, et al.
Science (2018) Vol. 363, Iss. 6427, pp. 649-654
Open Access | Times Cited: 277
Talar Tokatlian, Benjamin J. Read, Christopher A. Jones, et al.
Science (2018) Vol. 363, Iss. 6427, pp. 649-654
Open Access | Times Cited: 277
Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice
Pia Dosenovic, Lotta von Boehmer, Amelia Escolano, et al.
Cell (2015) Vol. 161, Iss. 7, pp. 1505-1515
Open Access | Times Cited: 263
Pia Dosenovic, Lotta von Boehmer, Amelia Escolano, et al.
Cell (2015) Vol. 161, Iss. 7, pp. 1505-1515
Open Access | Times Cited: 263
Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies
Bryan Briney, Devin Sok, Joseph G. Jardine, et al.
Cell (2016) Vol. 166, Iss. 6, pp. 1459-1470.e11
Open Access | Times Cited: 258
Bryan Briney, Devin Sok, Joseph G. Jardine, et al.
Cell (2016) Vol. 166, Iss. 6, pp. 1459-1470.e11
Open Access | Times Cited: 258
Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies
Laura E. McCoy, Marit J. van Gils, Gabriel Ozorowski, et al.
Cell Reports (2016) Vol. 16, Iss. 9, pp. 2327-2338
Open Access | Times Cited: 243
Laura E. McCoy, Marit J. van Gils, Gabriel Ozorowski, et al.
Cell Reports (2016) Vol. 16, Iss. 9, pp. 2327-2338
Open Access | Times Cited: 243
Native‐like Env trimers as a platform for HIV ‐1 vaccine design
Rogier W. Sanders, John P. Moore
Immunological Reviews (2017) Vol. 275, Iss. 1, pp. 161-182
Open Access | Times Cited: 235
Rogier W. Sanders, John P. Moore
Immunological Reviews (2017) Vol. 275, Iss. 1, pp. 161-182
Open Access | Times Cited: 235
Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires
Ming Tian, Cheng Cheng, Xuejun Chen, et al.
Cell (2016) Vol. 166, Iss. 6, pp. 1471-1484.e18
Open Access | Times Cited: 230
Ming Tian, Cheng Cheng, Xuejun Chen, et al.
Cell (2016) Vol. 166, Iss. 6, pp. 1471-1484.e18
Open Access | Times Cited: 230
Engineered immunogen binding to alum adjuvant enhances humoral immunity
Tyson J. Moyer, Yu Kato, Wuhbet Abraham, et al.
Nature Medicine (2020) Vol. 26, Iss. 3, pp. 430-440
Open Access | Times Cited: 224
Tyson J. Moyer, Yu Kato, Wuhbet Abraham, et al.
Nature Medicine (2020) Vol. 26, Iss. 3, pp. 430-440
Open Access | Times Cited: 224